Product
Carboplatin/Nedaplatin
1 clinical trial
2 indications
Indication
Esophageal cancerIndication
Neoadjuvant ImmunotherapyClinical trial
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Locally Advanced Esophageal CarcinomaStatus: Recruiting, Estimated PCD: 2023-12-31